✦ LIBER ✦

PCV93 THROMBOPROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT: COST-UTILITY ANALYSIS OF RIVAROXABAN VERSUS ENOXAPARIN IN SLOVAKIA

✍ Scribed by M Lukac; J Bielik; M Lees; D Tomek; V Foltan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV86 COST-UTILITY ANALYSIS OF RIVAROXAB

✍ R Pereira; A Diamantopoulos; J Bielik; M Lees; D Tomek; M Lukac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Rivaroxaban versus enoxaparin for thromb

✍ Yong Bing Cao; Jun Dong Zhang; Hui Shen; Yuan Ying Jiang 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 659 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS28 Cost-Benefit-Analysis of Thrombopr

✍ K. Heidorn; W. Mittelmeier; G. Kundt; R. Skripitz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB